{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:19:08Z","timestamp":1794640748725,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0901-8","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T13:14:13Z","timestamp":1536585253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study"],"prefix":"10.1186","volume":"13","author":[{"name":"on behalf of TOSCA Consortium and TOSCA Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus J.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Belousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana P.","family":"Benedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume B.","family":"d\u2019Aug\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Fladrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hertzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"Jozwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Chris","family":"Kingswood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Macaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finbar","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Touraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Youroukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zonnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"901_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345\u201356.","journal-title":"N Engl J Med"},{"key":"901_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:255\u201365.","journal-title":"Pediatr Neurol"},{"key":"901_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14:733\u201345.","journal-title":"Lancet Neurol"},{"key":"901_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/ejpn.2001.0538","volume":"6","author":"P Curatolo","year":"2002","unstructured":"Curatolo P, Verdecchia M, Bombardieri R. Tuberous sclerosis complex: a review of neurological aspects. Eur J Paediatr Neurol. 2002;6:15\u201323.","journal-title":"Eur J Paediatr Neurol"},{"key":"901_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ de Vries","year":"2015","unstructured":"de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 2015;52:25\u201335.","journal-title":"Pediatr Neurol"},{"key":"901_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","volume":"52","author":"L Leclezio","year":"2015","unstructured":"Leclezio L, Jansen A, Whittemore VH, de Vries PJ. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist. Pediatr Neurol. 2015;52:16\u201324.","journal-title":"Pediatr Neurol"},{"key":"901_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1108\/AIA-12-2015-0025","volume":"2","author":"L Leclezio","year":"2016","unstructured":"Leclezio L, de Vries P. Towards an improved understanding of TSC-associated neuropsychiatric disorders (TAND). Adv Autism. 2016;2:76\u201383.","journal-title":"Adv Autism"},{"key":"901_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/08830738040190090601","volume":"19","author":"P Prather","year":"2004","unstructured":"Prather P, de Vries PJ. Behavioral and cognitive aspects of tuberous sclerosis complex. J Child Neurol. 2004;19:666\u201374.","journal-title":"J Child Neurol"},{"key":"901_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","volume":"11","author":"DA Muzykewicz","year":"2007","unstructured":"Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav. 2007;11:506\u201313.","journal-title":"Epilepsy Behav"},{"issue":"Pt 1","key":"901_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2788.1993.tb00868.x","volume":"37","author":"A Hunt","year":"1993","unstructured":"Hunt A. Development, behaviour and seizures in 300 cases of tuberous sclerosis. J Intellect Disabil Res. 1993;37(Pt 1):41\u201351.","journal-title":"J Intellect Disabil Res"},{"key":"901_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1469-8749.1994.tb11765.x","volume":"36","author":"IC Gillberg","year":"1994","unstructured":"Gillberg IC, Gillberg C, Ahlsen G. Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev Med Child Neurol. 1994;36:50\u20136.","journal-title":"Dev Med Child Neurol"},{"key":"901_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00787-006-0570-3","volume":"16","author":"PJ de Vries","year":"2007","unstructured":"de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007;16:16\u201324.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"901_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2017.12.006","volume":"81","author":"L Leclezio","year":"2018","unstructured":"Leclezio L, Gardner-Lubbe S, de Vries PJ. Is it feasible to identify natural clusters of TSC-associated neuropsychiatric disorders (TAND)? Pediatr Neurol. 2018;81:38\u201344.","journal-title":"Pediatr Neurol"},{"key":"901_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1469-8749.1983.tb13771.x","volume":"25","author":"A Hunt","year":"1983","unstructured":"Hunt A. Tuberous sclerosis: a survey of 97 cases. III: family aspects. Dev Med Child Neurol. 1983;25:353\u20137.","journal-title":"Dev Med Child Neurol"},{"key":"901_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ridd.2017.03.007","volume":"64","author":"L Wilde","year":"2017","unstructured":"Wilde L, Eden K, de Vries P, Moss J, Welham A, Oliver C. Self-injury and aggression in adults with tuberous sclerosis complex: frequency, associated person characteristics, and implications for assessment. Res Dev Disabil. 2017;64:119\u201330.","journal-title":"Res Dev Disabil"},{"key":"901_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ de Vries","year":"2007","unstructured":"de Vries PJ, Howe CJ. The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment. Trends Mol Med. 2007;13:319\u201326.","journal-title":"Trends Mol Med"},{"key":"901_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","volume":"53","author":"D Ehninger","year":"2009","unstructured":"Ehninger D, de Vries PJ, Silva AJ. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res. 2009;53:838\u201351.","journal-title":"J Intellect Disabil Res"},{"key":"901_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10519-010-9399-0","volume":"41","author":"R Waltereit","year":"2011","unstructured":"Waltereit R, Japs B, Schneider M, de Vries PJ, Bartsch D. Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behav Genet. 2011;41:364\u201372.","journal-title":"Behav Genet"},{"key":"901_CR19","doi-asserted-by":"crossref","unstructured":"Schneider M, de Vries PJ, Schonig K, Rossner V, Waltereit R. mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both TSC2 haploinsufficiency and developmental status epilepticus. Eur Arch Psychiatry Clin Neurosci. 2017;267(5):455\u201363.","DOI":"10.1007\/s00406-016-0703-8"},{"key":"901_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/WCO.0b013e32834451c4","volume":"24","author":"P Tsai","year":"2011","unstructured":"Tsai P, Sahin M. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr Opin Neurol. 2011;24:106\u201313.","journal-title":"Curr Opin Neurol"},{"key":"901_CR21","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3174\/ajnr.A3507","volume":"34","author":"AM Wong","year":"2013","unstructured":"Wong AM, Wang HS, Schwartz ES, Toh CH, Zimmerman RA, Liu PL, Wu YM, Ng SH, Wang JJ. Cerebral diffusion tensor MR tractography in tuberous sclerosis complex: correlation with neurologic severity and tract-based spatial statistical analysis. AJNR Am J Neuroradiol. 2013;34:1829\u201335.","journal-title":"AJNR Am J Neuroradiol"},{"key":"901_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1017\/S0033291701004561","volume":"31","author":"K Ridler","year":"2001","unstructured":"Ridler K, Bullmore ET, De Vries PJ, Suckling J, Barker GJ, Meara SJ, Williams SC, Bolton PF. Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol Med. 2001;31:1437\u201346.","journal-title":"Psychol Med"},{"key":"901_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000280578.99900.96","volume":"70","author":"FE Jansen","year":"2008","unstructured":"Jansen FE, Braams O, Vincken KL, Algra A, Anbeek P, Jennekens-Schinkel A, Halley D, Zonnenberg BA, van den Ouweland A, van Huffelen AC, et al. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology. 2008;70:908\u201315.","journal-title":"Neurology"},{"key":"901_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, Wheless JW, Baumgartner JE, Roa BB, Wilson CM, et al. Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9:88\u2013100.","journal-title":"Genet Med"},{"key":"901_CR25","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ejhg.2011.241","volume":"20","author":"AM van Eeghen","year":"2012","unstructured":"van Eeghen AM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA. Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet. 2012;20:510\u20135.","journal-title":"Eur J Hum Genet"},{"key":"901_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/jmedgenet-2015-103154","volume":"52","author":"HT Wong","year":"2015","unstructured":"Wong HT, McCartney DL, Lewis JC, Sampson JR, Howe CJ, de Vries PJ. Intellectual ability in tuberous sclerosis complex correlates with predicted effects of mutations on TSC1 and TSC2 proteins. J Med Genet. 2015;52:815\u201322.","journal-title":"J Med Genet"},{"key":"901_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-014-0182-9","volume":"9","author":"JC Kingswood","year":"2014","unstructured":"Kingswood JC, Bruzzi P, Curatolo P, de Vries PJ, Fladrowski C, Hertzberg C, Jansen AC, Jozwiak S, Nabbout R, Sauter M, et al. TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex. Orphanet J Rare Dis. 2014;9:182.","journal-title":"Orphanet J Rare Dis"},{"key":"901_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood JC, d'Augeres GB, Belousova E, Ferreira JC, Carter T, Castellana R, Cottin V, Curatolo P, Dahlin M, de Vries PJ, et al. TuberOus SClerosis registry to increase disease awareness (TOSCA) - baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12:2.","journal-title":"Orphanet J Rare Dis"},{"key":"901_CR29","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use. Int Dig Health Legis 1997, 48:231\u2013234."},{"issue":"2194","key":"901_CR30","first-page":"2191","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310(2194):2191.","journal-title":"JAMA"},{"key":"901_CR31","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.","edition":"5"},{"key":"901_CR32","unstructured":"World Health Organization. ICD-10: international statistical classification of diseases and related health problems. 10th revision. 2nd ed: Geneva World Health Organization; 2004."},{"key":"901_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.yebeh.2008.05.010","volume":"13","author":"CM Kopp","year":"2008","unstructured":"Kopp CM, Muzykewicz DA, Staley BA, Thiele EA, Pulsifer MB. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behav. 2008;13:505\u201310.","journal-title":"Epilepsy Behav"},{"key":"901_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243\u201354.","journal-title":"Pediatr Neurol"},{"key":"901_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00787-005-0443-1","volume":"14","author":"P de Vries","year":"2005","unstructured":"de Vries P, Humphrey A, McCartney D, Prather P, Bolton P, Hunt A. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis. Eur Child Adolesc Psychiatry. 2005;14:183\u201390.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"901_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13023-015-0371-1","volume":"10","author":"A Vignoli","year":"2015","unstructured":"Vignoli A, La Briola F, Peron A, Turner K, Vannicola C, Saccani M, Magnaghi E, Scornavacca GF, Canevini MP. Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers. Orphanet J Rare Dis. 2015;10:154.","journal-title":"Orphanet J Rare Dis"},{"key":"901_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2310\/7010.2006.00046","volume":"21","author":"V Wong","year":"2006","unstructured":"Wong V. Study of the relationship between tuberous sclerosis complex and autistic disorder. J Child Neurol. 2006;21:199\u2013204.","journal-title":"J Child Neurol"},{"key":"901_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68:64\u201380.","journal-title":"Am J Hum Genet"},{"key":"901_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1017\/S0033291702007092","volume":"33","author":"C Joinson","year":"2003","unstructured":"Joinson C, O'Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003;33:335\u201344.","journal-title":"Psychol Med"},{"key":"901_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/01.wnl.0000250330.44291.54","volume":"68","author":"EB Winterkorn","year":"2007","unstructured":"Winterkorn EB, Pulsifer MB, Thiele EA. Cognitive prognosis of patients with tuberous sclerosis complex. Neurology. 2007;68:62\u20134.","journal-title":"Neurology"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0901-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:32:01Z","timestamp":1720585921000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0901-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0901-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients (or their legal representatives) provided written informed consent before enrolling in the TOSCA disease registry. The study was designed, implemented, and reported in accordance with the principles of Good Clinical Practice, Good Pharmacoepidemiology Practices of the International Society for Pharmacoepidemiology (ISPE 2008), the STROBE (Strengthening and Reporting of Observational Studies in Epidemiology) guidelines, and the ethical principles laid down in the Declaration of Helsinki, and all local regulations. The study protocol and all amendments were reviewed and approved (if applicable) by independent ethics committee\/institutional review board for each center: National Hospital Organization Central Ethics Committee; Gazi University Clinical Research Ethics Committee; Independent Multidisciplinary Committee on Ethical Review of Clinical Trials; Peking Union Medical College Hospital; Commissie Medische Ethiek UZ Brussel; CNIL (Commission National de l\u2019Informatique et des Libert\u00e9s), CCTIRS (Comit\u00e9 Consultatif sur le traitement de l\u2019information en mati\u00e8re de recherche dans le domaine de la sant\u00e9); Comit\u00e9 Etico Investigaci\u00f3n Cl\u00ednica de Euskadi (CEIC-E); Consejeria de Salud y Bienestar Social, Direcci\u00f3n General de Calidad, Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n, Comit\u00e9 Coordinador de \u00c9tica de la Investigaci\u00f3n Biom\u00e9dica de Andaluc\u00eda; Research Ethics Committee of the University of Tartu (UT REC); Ethikkommission der Medizinischen Universit\u00e4t Graz; North Wales REC \u2013 West; Regionala Etikpr\u00f6vningsn\u00e4mnden i G\u00f6teborg; REK \u2013 Regionale komiteer for medisinsk og helsefaglig forskningsetikk; Komisja Bioetyczna przy Instytucie \u201cPomnik Centrum Zdrowia Dziecka\u201d; Ethikkommission bei der Ludwig-Maximilians-Universitat M\u00fcnchen; Hokkaido University Hospital Independent clinical research Institutional Ethics Committee; Medical Juntendo University Institutional Ethics Committee; National Center for Chile Health and Deveropment of IRB; Osaka University Hospital of IRB; Ethics Committee at Moscow Institute of Pediatrics and Pediatric Surgery; Peking University First Hospital; Sanbo Brain Hospital Capital Medical University; Tianjin Children\u2019s Hospital; Childrens Hospital Of Fudan University; Zhongshan Hospital Fudan University; Fudan University Shanghai Cancer Center; The Second Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital, Sun Yan-Sen University; The First Affiliated Hospital Of Guangzhou Medical University; Shenzhen Children\u2019s Hospital; West China Hospital, Sichuan University; Xijing Hospital; Children\u2019s Hospital of Chongqing Medical University; Wuhan Children\u2019s Hospital; The second affiliated hospital of Xi\u2019an jiaotong university; Guangdong 999 brain hospital; Seoul National University Hospital Institutional Review Board; National Taiwan University Hospital (NTUH) Research Ethics Committee (REC); Institutional Review Board of the Taichung Veterans General Hospital; Institutional Review Board of Chung Shan Medical University Hospital; Institutional Review Board, Tungs\u2019 Taichung MetroHarbor Hospital; Institutional Review Board of National Cheng Kung University Hospital; Metro South Human Research Ethics Committee; Sydney Children\u2019s Hospital Network Human Research Ethics Committee; St Vincents Hospital Human Research Ethics Committee; Royal Melbourne Hospital Human Research Ethics Committee; Siriraj Institutional Review Board; The Institutional Review board, Faculty of Medicine, Chulalongkorn University, 3rd Floor, Ananthamahidol Building, King Chulalongkorn Memorial Hospital; The committee on Human Rights Related to Research Involving Human Subjects; Institutional Review board, Royal Thai Army Medical Department IRB RTA, 5th Floor, Phramongkutklaowejvitya Building, Phramongkutklao College of Medicine; Research Ethics Committee, Faculty of Medicine, Chiang Mai University; Research and Development, Queen Sirikit National Institute of Child Health; Human Research Ethics Committee, Faculty of Health Sciences, University of Cape Town; Shaare Zedek Meidcla center Helsinki comittee; Sheba Medical center Helsinki comittee; Tel Aviv Sourasly Medical center Helsinki comittee; General University Hospital of Patras Ethics Committee; Pendeli Children\u2019s Hospital Ethics Committee; General University Hospital of Athens \u201cG. Gennimatas\u201d Ethics Committee; Evaggelismos General Hospital Ethics Committee; General University Hospital of Thessaloniki \u201cAHEPA\u201d Ethics Committee; General University Hospital of Ionnina Ethics Committee; METC UMC Utrecht; Direcci\u00f3 General de Regulaci\u00f3, Planificaci\u00f3 i Recursos Sanitaris; Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica del Hospital Universitario Vall d\u2019Hebron de Barcelona, Generalitat de Catalunya.Departament de Salut; Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica Hospital Universitario La Paz; Direcci\u00f3n General de Ordenaci\u00f3n e Inspecci\u00f3n, Consejer\u00eda de Sanidad Comunidad de Madrid, Servicios de Control Farmac\u00e9utico y Productos Sanitarios; Comit\u00e9 Etico Investigaci\u00f3n Cl\u00ednica del Hospital Universitario y Polit\u00e9cnico de La Fe; Direcci\u00f3n General de Farm\u00e0cia i Productes Sanitaris, Generalitat de Valencia; Comit\u00e9 de \u00c9tica de la Investigaci\u00f3n de Centro de Granada; Instituto Aragon\u00e9s de Ciencias de la Salud (IACS);; Comit\u00e9 Etico Investigaci\u00f3n Cl\u00ednica Regional del Principado de Asturias;; Comit\u00e9 Etico Investigaci\u00f3n Cl\u00ednica Hospital 12 de Octubre;, Comit\u00e9 Etico Investigaci\u00f3n Cl\u00ednica Hospital Universitario Virgen de la Arrixaca;; Secci\u00f3n de Ordenaci\u00f3n e Inspecci\u00f3n Farmac\u00e9utica Departamento de Salud; Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica del Hospital Universitario del R\u00edo Hortega de Valladolid;, Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Centro Hospitalar de Lisboa Ocidental, EPE; Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Centro Hospitalar do Porto, E.P.E; Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Centro Hospitalar Lisboa Central, EPE; Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Hospital Garcia de Orta, EPE; Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Centro Hospitalar de S\u00e3o Jo\u00e3o, EPE; Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Hospital Professor Doutor Fernando Fonseca, EPE; Comiss\u00e3o de \u00c9tica para a Sa\u00fade (CES), Centro Hospitalar do Algarve, EPE (Unidade de Faro); LUHS Kaunas Regional Biomedical Research Ethics Committee; Paula Stradi\u0146a kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas, Att\u012bst\u012bbas biedr\u012bbas Kl\u012bnisk\u0101s izp\u0113tes \u0112tikas komiteja, Ethics Committee for Clinical Research; Komisija Republike Slovenije za medicinsko etiko; Comitato Etico Indipendente Presso La Fondazione Ptv Policlinico Tor Vergata Di Roma; Comitato Etico Regione Calabria Sezione Centro c\/o A.O.U. Mater Domini Di Catanzaro; Comitato Etico Azienda Ospedaliera Universitaria Di Cagliari; Comitato Etico Cardarelli-Santobono c\/o Ao Cardarelli; Comitato Etico Per La Sperimentazione Clinica Delle Province Di Verona E Rovigo, Presso Aoui Verona; Eticka Komise Fn Brno; Eticka Komisia Dfnsp Bratislava; Eticka Komisia Pri Dfn Kosice; Eticka Komisia Bratislavskeho Samospravneho Kraja; Comisia Na\u021bional\u0103 de Bioetic\u0103 a Medicamentului \u0219i a Dispozitivelor Medicale; Comitato Etico Milano area 1 c\/o ASST FBF Sacco - P.O. L. Sacco; Comit\u00e9 de \u00c9tica de la Investigaci\u00f3n de Centro Hospital Universitario Virgen del Roc\u00edo; Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica Fundaci\u00f3 Sant Joan de D\u00e9u Generalitat de Catalunya. Departament de Salut; Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica Hospital Infantil Universitario Ni\u00f1o Jes\u00fas; Consejer\u00eda de Sanidad Direcci\u00f3n General de Salus P\u00fablica Junta de Castilla Le\u00f3n; Direcci\u00f3n General de Asistencia Sanitaria, Consejer\u00eda de Sanidad Gobierno del Principado de Asturias; Direcci\u00f3n General de Planificaci\u00f3n, Ordenaci\u00f3n Sanitaria y Farmac\u00e9utica e Investigaci\u00f3n, Consejeria de Sanidad y Pol\u00edtica Social Regi\u00f3n de Murcia; Ethics Committee at Moscow Institute of Pediatrics and Pediatric Surgery; Paula Stradi\u0146a kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas, Att\u012bst\u012bbas biedr\u012bbas Kl\u012bnisk\u0101s izp\u0113tes \u0112tikas komiteja, Ethics Committee for Clinical Research; The First Affiliated Hospital of The Fourth Military Medical University; Zhongshan hospital fudan university.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients were informed that the reason for enrolling in the study was to collect natural history data for scientific analysis and publication (an obligation mandated by the Good Clinical Practice guidelines) and they signed consent forms with that understanding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P.J.dV., E.B., T.C., V.C., P.C., G.B.d\u2019A., J.C.K., J.C.F., M.F., C.F., C.H., S.J., R.N., F.O\u2019C, J.Q., M.S., R.T., M.D., J.A.L., A.M., S.Y., M.P.B., B.Z. and A.C.J. received honoraria and support for the travels from Novartis. V.C. received personal fees for consulting, lecture fees and travel from Actelion, Bayer, Biogen Idec, Boehringer Ingelheim, Gilead, GSK, MSD, Novartis, Pfizer, Roche, Sanofi; grants from Actelion, Boehringer Ingelheim, GSK, Pfizer, Roche; personal fees for developing educational material from Boehringer Ingelheim and Roche. P.J.dV. has been on the study steering group of the EXIST-1, 2 and 3 studies sponsored by Novartis, and co-PI on two investigator-initiated studies part-funded by Novartis. RN received grant support, paid to her institution, from Eisai and lectures fees from Nutricia, Eisai, Advicenne and GW Pharma. Y.T. received personal fee from Novartis for lecture and for copyright of referential figures from the journals, and received grant from Japanese government for intractable epilepsy research. S.J. was partly financed by the EC Seventh Framework Programme (FP7\/2007\u20132013; EPISTOP, grant agreement no. 602391), the Polish Ministerial funds for science (years 2013\u20132018) for the implementation of international cofinanced project and the grant EPIMARKER of the Polish National Center for Research and Development No STRATEGMED3\/306306\/4\/2016. J.C.K., P.C., C.H., J.A.L., and J.Q. received research grant from Novartis. R.M., L.D\u2019A. and S.S. are employees of Novartis. V.S. reported no competing interest. This study was funded by Novartis Pharma AG. All authors approved the final version of the manuscript prior to submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"157"}}